NewsRamp Editorial Team
NewsRamp
@newsramp
NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
4408 articles
Articles
FAQ: Annovis Bio's Buntanetap Shows Cognitive Improvement in Parkinson's Patients with Amyloid Co-Pathology
What is the main finding from Annovis Bio's recent Parkinson's disease study? Buntanetap halted cognitive decline across all patients in the Phase 3 early Parkinson's disease study and delivered the strongest benefit in patients with mild dementia and amyloid co-pathology, reversing cognitive deterioration in this subgroup....
November 17, 2025Read the full article
FAQ: CNS Pharmaceuticals Q3 2025 Results and TPI 287 Glioblastoma Treatment Progress
What is CNS Pharmaceuticals and what does the company develop? CNS Pharmaceuticals is a clinical-stage pharmaceutical company that develops anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system. What is TPI 287 and how does it work? TPI 287 is an abeotaxane d...
November 17, 2025Read the full article
FAQ: TransCode Therapeutics Appoints Dr. Michel Janicot as Senior Development Officer
What is the main announcement in this content? TransCode Therapeutics, Inc. (NASDAQ: RNAZ) has appointed Dr. Michel Janicot as consultant Senior Development Officer to support the advancement of TTX-MC138 and Seviprotimut-L. Who is Dr. Michel Janicot and what experience does he bring? Dr. Michel Janicot is the founder of JM...
November 17, 2025Read the full article
FAQ: NRx Pharmaceuticals Q3 2025 Results and Regulatory Progress for NRX-100 and NRX-101
What are the key developments NRx Pharmaceuticals reported in Q3 2025? NRx reported its first revenue-generating activities and significant regulatory progress for NRX-100 and NRX-101, including expanded Fast Track status for NRX-100 in suicidal depression and initiation of NDA filings with Breakthrough Therapy Designation ...
November 17, 2025Read the full article
FAQ: Safe Pro Group's Operational Progress and Strategic Investments
What is the main announcement from Safe Pro Group? Safe Pro Group reported operational advances across its AI, aerial services, and ballistic-protection businesses following more than $20 million in new strategic investments, including accelerated development of its SpotlightAI threat-detection platform and progress toward ...
November 17, 2025Read the full article
FAQ: Datavault AI's Q3 Revenue Growth, Licensing Deals, and RWA Tokenization Pipeline
What is Datavault AI and what does the company do? Datavault AI (NASDAQ: DVLT) is a company that provides AI-driven solutions for data valuation and monetization in the Web 3.0 environment through its cloud-based platform, serving industries including sports & entertainment, biotech, education, fintech, real estate, healthc...
November 17, 2025Read the full article
FAQ: China's Record EV Sales in October and TinyGems Platform Overview
What is the main news reported in this content? China sold 1.7 million electric and plug-in hybrid vehicles in October, setting a new monthly record for the country's rapidly expanding electric vehicle market. Who provided the data about China's EV sales? The data comes from the China Association of Automobile Manufacturers...
November 17, 2025Read the full article
FAQ: NanoViricides' NV-387 Broad-Spectrum Antiviral Development and Quarterly Report
What is NanoViricides and what does the company do? NanoViricides, Inc. is a publicly traded clinical stage company (NYSE American: NNVC) that creates special purpose nanomaterials for antiviral therapy, developing novel nanoviricide drug candidates based on technology licensed from TheraCour Pharma, Inc. What is NV-387 and...
November 17, 2025Read the full article
FAQ: Foxconn's AI Demand Optimism and TechMediaWire Services
What is the main topic of this content? Foxconn, the world's largest electronics manufacturer and key supplier for Nvidia and Apple, has expressed strong optimism about growing global demand for artificial intelligence (AI) products and expects AI to continue driving its growth into 2026. Why is Foxconn's optimism about AI ...
November 17, 2025Read the full article
FAQ: Trilogy Metals Inc. and the Ambler Mining District Development
What is Trilogy Metals Inc. and what is their main focus? Trilogy Metals Inc. (NYSE American: TMQ, TSX: TMQ) is a company focused on exploring and developing North America's essential mineral assets through their Upper Kobuk Mineral Projects in Alaska's Ambler Mining District. What are the Upper Kobuk Mineral Projects (UKMP...
November 17, 2025Read the full article
FAQ: Gold Price Surge and USD Weakness - Key Insights
What is the main topic of this content? The content discusses gold prices re-crossing the $4,200 mark during Asian trading on Friday, driven by USD weakness and investor concerns about the US economic outlook following the government shutdown. Why did gold prices rise above $4,200? Gold prices rose due to growing investor c...
November 17, 2025Read the full article
Sanderson Lacrosse Online Store Expansion FAQ
What is the main announcement in this content? Sanderson Lacrosse has officially expanded its online store, bringing decades of lacrosse expertise and a massive product lineup to players across North America and beyond. Who operates Sanderson Lacrosse and what is their background? Sanderson Lacrosse is operated by Deron San...
November 17, 2025Read the full article
FAQ: AI Search Dominance and Business Visibility in the Age of AI Assistants
What is the main topic of this new book? The book addresses the shift from traditional search engines to AI assistants and introduces Answer Engine Optimization (AEO) as a new discipline to help businesses remain visible in AI searches. Why is this shift to AI search assistants significant for businesses? Traditional search...
November 17, 2025Read the full article
FAQ: Datavault AI's $8 Million Tokenization Agreement with Triton Geothermal
What is the main announcement in this content? Datavault AI has entered a Tokenization Service Agreement with Triton Geothermal that includes up to $8 million in tokenization fees tied to a planned $125 million digital token offering, plus five percent of future token transaction fees. Why is this agreement significant for ...
November 17, 2025Read the full article
FAQ: Alamo Promenade Grand Opening and Happy Trails Event
The Alamo will celebrate the grand opening of the Alamo Promenade, a new pedestrian-friendly gateway featuring historical statues and enhanced public spaces that connect the Alamo to the Briscoe Western Art Museum. This milestone event highlights statewide support for preserving Texas history.
November 17, 2025Read the full article
FAQ: Roamin Restrooms Luxury Portable Restroom Services in Round Rock and Austin
Roamin Restrooms Joins the Round Rock Chamber to Bring Luxury Portable Restrooms to Central Texas events.
November 17, 2025Read the full article
FAQ: Preparing Special Needs Students for Inclusive Classroom Celebrations
What is the main purpose of creating inclusive classroom celebrations for special needs students? The main purpose is to transform classroom celebrations into safe, meaningful experiences that help special needs students practice social skills, emotional regulation, and flexibility while feeling included and supported. Why ...
November 17, 2025Read the full article
FAQ: Stonegate Capital Partners Coverage Update on Alpha Cognition Inc. (ACOG) Q3 2025
What is the main focus of Stonegate Capital Partners' updated coverage on Alpha Cognition? The update focuses on Alpha Cognition's Q3 2025 performance, particularly the accelerating commercialization of ZUNVEYL in the U.S. long-term care channel, financial results, R&D progress, and the company's valuation outlook. How did ...
November 17, 2025Read the full article
FAQ: Stonegate Capital Partners' Q3 2025 Coverage Update on Aemetis, Inc.
What is the main focus of Stonegate Capital Partners' update on Aemetis? The update focuses on Aemetis' Q3 2025 results, emphasizing the strengthening Dairy RNG platform, revenue growth from India biodiesel and California ethanol, and the company's positioning to benefit from multiple policy tailwinds and credit monetizatio...
November 17, 2025Read the full article
FAQ: Doug Wendt's Bridge Builder Award from Global Chamber® New York City
What is this announcement about? Doug Wendt, Co-Founder & Senior Partner of Wendt Partners, received the 2025 "Bridge Builder" award from Global Chamber New York City for his commitment to supporting cross-metro and cross-border business connections. Who received the Bridge Builder award and what is his role? Doug Wendt, wh...
November 17, 2025Read the full article
Aquafil Group Q3 2025 Performance and Stonegate Capital Partners Coverage Update
What is the main topic of this Stonegate Capital Partners coverage update? This coverage update analyzes Aquafil Group's Q3 2025 financial performance, highlighting resilient profitability despite revenue challenges, with specific focus on EBITDA margin improvement, regional performance, and the company's valuation. How did...
November 17, 2025Read the full article